Difference between revisions of "Dissolution testing"

From LIMSWiki
Jump to: navigation, search
(Recreated article due to necessary redirect.)
 
m (Changed cat)
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
In the pharmaceutical industry, drug '''dissolution testing''' is routinely used to provide critical [[in vitro]] drug release information for both [[quality control]] purposes, i.e., to assess batch-to-batch consistency of solid oral dosage forms such as tablets, and drug development, i.e., to predict [[in vivo]] drug release profiles.<ref name="Bai1">{{cite journal|author=Ge Bai, Yimin Wang and Piero M. Armenante |title=Velocity profiles and shear strain rate variability in the USP Dissolution Testing Apparatus 2 at Different Impeller Agitation Speeds |journal=International Journal of Pharmaceutics |volume=403 |issue=1–2 |pages=1–14 |year=17 January 2011 |doi=10.1016/j.ijpharm.2010.09.022}}</ref>  
+
In the pharmaceutical industry, drug '''dissolution testing''' is routinely used to provide critical in vitro drug release [[information]] for both quality control purposes, i.e., to assess batch-to-batch consistency of solid oral dosage forms such as tablets, and drug development, i.e., to predict [[in vivo]] drug release profiles.<ref name="Bai1">{{cite journal|author=Ge Bai, Yimin Wang and Piero M. Armenante |title=Velocity profiles and shear strain rate variability in the USP Dissolution Testing Apparatus 2 at Different Impeller Agitation Speeds |journal=International Journal of Pharmaceutics |volume=403 |issue=1–2 |pages=1–14 |year=17 January 2011 |doi=10.1016/j.ijpharm.2010.09.022}}</ref>  
  
 
==References==
 
==References==
 
{{reflist}}
 
{{reflist}}
 +
 +
<!---Place all category tags here-->
 +
[[Category:Testing terminology]]

Latest revision as of 19:31, 6 August 2014

In the pharmaceutical industry, drug dissolution testing is routinely used to provide critical in vitro drug release information for both quality control purposes, i.e., to assess batch-to-batch consistency of solid oral dosage forms such as tablets, and drug development, i.e., to predict in vivo drug release profiles.[1]

References

  1. Ge Bai, Yimin Wang and Piero M. Armenante (17 January 2011). "Velocity profiles and shear strain rate variability in the USP Dissolution Testing Apparatus 2 at Different Impeller Agitation Speeds". International Journal of Pharmaceutics 403 (1–2): 1–14. doi:10.1016/j.ijpharm.2010.09.022.